Mirum Pharmaceuticals, Inc.

Pharmaceutical Preparations·FOSTER CITY, CA·FY end 12/31·CIK 1759425

CEO Pay Ratio

24:1

Christopher Peetz

CEO Total Comp

$10.4M

Christopher Peetz

Median Employee

$434,769

Revenue

$521.3M

FY 2025

Net Income

-$23.4M

FY 2025

Free Cash Flow

$54.9M

FY 2025

Net Margin

-4.5%

Insider Net (180d)

-$3.7M

2 buys / 36 sales

CEO Pay Accountability

CEO comp as % of net income

-44.69%

For every $1,000 of profit, $-446.91 flows to the CEO.

CEO comp as % of buybacks

—

No buyback data for the most recent fiscal year.

5-year history · USD

Metric	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	Trend
Revenue	$521.3M	$336.9M	$186.4M	$77.1M	$19.1M
Gross Profit	—	—	—	—	—	—
Operating Income	-$22.1M	-$87.6M	-$109.2M	-$131.2M	-$173.4M
Net Income	-$23.4M	-$87.9M	-$163.4M	-$135.7M	-$84.0M
Operating CF	$55.8M	$10.3M	-$70.9M	-$120.1M	-$132.8M
Capex	$954.0K	$993.0K	$109.0K	$278.0K	$24.0K
Free Cash Flow	$54.9M	$9.3M	-$71.1M	-$120.4M	-$132.8M
Buybacks	—	—	—	—	—	—
Dividends	—	—	—	—	—	—

Gross Margin	—	—	—	—	—	—
Operating Margin	-4.2%	-26.0%	-58.6%	-170.3%	-906.1%
Net Margin	-4.5%	-26.1%	-87.7%	-176.0%	-438.9%
FCF Margin	10.5%	2.8%	-38.1%	-156.3%	-693.8%
R&D / Revenue	—	—	—	—	—	—
Effective Tax	-9.0%	-1.2%	-0.6%	4.5%	-0.0%
Debt / Equity	—	—	—	—	—	—
Buybacks / FCF	—	—	—	—	—	—

FY 2025

Executive	Salary	Stock	Options	Bonus / Inc.	Other	Total
Christopher PeetzChief Executive Officer	$755.0K	$3.7M	$4.9M	$1.1M	$14.0K	$10.4M
Peter RadovichPresident and Chief Operating Officer	$572.5K	$1.2M	$1.6M	$572.5K	$14.0K	$4.0M
Eric BjerkholtChief Financial Officer	$520.0K	$959.6K	$1.3M	$468.0K	$14.0K	$3.2M
Joanne QuanM.D. Chief Medical Officer	$520.0K	$959.6K	$1.3M	$468.0K	$14.0K	$3.2M